4//SEC Filing
E&Investment, Inc. 4
Accession 0001437749-22-018053
CIK 0001638287other
Filed
Jul 27, 8:00 PM ET
Accepted
Jul 28, 9:23 PM ET
Size
9.7 KB
Accession
0001437749-22-018053
Insider Transaction Report
Form 4
E&Investment, Inc.
10% Owner
Transactions
- Other
Common Stock
2022-07-26−1,445,267→ 2,890,533 total(indirect: Held by The E&Healthcare Investment Fund II)
Holdings
- 140,147
Common Stock
- 1,121,190(indirect: Held by The E&Healthcare Investment Fund No. 6)
Common Stock
- 1,864,799(indirect: Held by The E&Healthcare Investment Fund No. 7)
Common Stock
E&Healthcare Investment Fund II
10% Owner
Transactions
- Other
Common Stock
2022-07-26−1,445,267→ 2,890,533 total(indirect: Held by The E&Healthcare Investment Fund II)
Holdings
- 140,147
Common Stock
- 1,121,190(indirect: Held by The E&Healthcare Investment Fund No. 6)
Common Stock
- 1,864,799(indirect: Held by The E&Healthcare Investment Fund No. 7)
Common Stock
Footnotes (6)
- [F1]E&Healthcare Investment Fund II distributed 1,445,267 shares to its partners on a pro rata basis, for no consideration.
- [F2]These shares are owned directly by The E&Healthcare Investment Fund II, a 10% owner of the Issuer, and indirectly by its sole general partner, E&Investment, Inc.
- [F3]E&Investment, Inc. disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein.
- [F4]E&Investment, Inc. received a pro rata distribution from E&Healthcare Investment Fund II.
- [F5]These shares are owned directly by The E&Healthcare Investment Fund No. 6, and indirectly by its sole general partner, E&Investment, Inc.
- [F6]These shares are owned directly by The E&Healthcare Investment Fund No.7, and indirectly by its sole general partner, E&Investment, Inc.
Documents
Issuer
NeuroBo Pharmaceuticals, Inc.
CIK 0001638287
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001796144
Filing Metadata
- Form type
- 4
- Filed
- Jul 27, 8:00 PM ET
- Accepted
- Jul 28, 9:23 PM ET
- Size
- 9.7 KB